logo

Equity Analysis

Company Profile
Detailed Quotes

Company News

    Divis Laboratories Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs
    BSE Code
    ISIN Demat
    Book Value()
    532488
    INE361B01024
    474.522963
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    DIVISLAB
    76.42
    104234.91
    EPS(TTM)
    Face Value()
    Div & Yield %:
    51.38
    2
    0.76
     
Zen Technologies consolidated net profit rises 72.97% in the March 2024 quarter
May 06,2024
Net profit of Zen Technologies rose 72.97% to Rs 34.94 crore in the quarter ended March 2024 as against Rs 20.20 crore during the previous quarter ended March 2023. Sales rose 47.47% to Rs 141.39 crore in the quarter ended March 2024 as against Rs 95.88 crore during the previous quarter ended March 2023.

For the full year,net profit rose 199.20% to Rs 127.88 crore in the year ended March 2024 as against Rs 42.74 crore during the previous year ended March 2023. Sales rose 100.98% to Rs 439.85 crore in the year ended March 2024 as against Rs 218.85 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales141.3995.88 47 439.85218.85 101
OPM %35.6636.70 -41.1033.18 -
PBDT52.2734.54 51 193.4275.78 155
PBT49.3533.02 49 183.7469.73 164
NP34.9420.20 73 127.8842.74 199